Titre:
  • Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Auteur:Aapro, Matti; van Wijk, F H; Bolis, G; Chevallier, Bernard; van der Burg, Maria; Poveda, Andrés; de Oliveira, Carlos Freire; Tumolo, Salvatore; Scotto di Palumbo, V; Piccart-Gebhart, Martine; Franchi, M; Zanaboni, Flavia; Lacave, Ángel Jiménez; Fontanelli, Rosanna; Favalli, Giuseppe; Zola, Paolo; Guastalla, Jean Paul; Rosso, Riccardo; Marth, C; Nooij, Marianne; Presti, Mauro; Scarabelli, Claudio; Splinter, Ted; Plöchl, Elzbieta; Beex, Louk; ten Bokkel Huinink, Wim; Forni, Mario; Melpignano, Mauro; Blake, Peter; Kerbrat, Pierre; Mendiola, César; Cervantes, Andrés; Goupil, A; Harper, Peter; Madronal, Catherina; Namer, Moïse; Scarfone, G; Stoot, J. E G M; Teodorovic, Ivana; Coens, Corneel; Vergote, Ignace; Vermorken, Jan Baptist
Informations sur la publication:Annals of oncology, 14, 3, page (441-448)
Statut de publication:Publié, 2003-03
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Mots-clés:Chemotherapy
Cisplatin
Doxorubin
Endometrial carcinoma
Phase III
Randomised clinical trial
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdg112
info:scp/0037352608